NEW YORK (TheStreet) -- Credit Suisse increased its price target on HCA Holdings (HCA) - Get Report  to $78 from $75 and reiterated its "outperform" rating on the stock.

The price target hike comes after the Nashville-based company reported its 2015 fourth quarter earnings results before the market open on Thursday.

HCA reported adjusted earnings of $1.69 per share, which beat analysts' expectations for earnings of $1.39 per share.

Revenue for the quarter rose by 6.4% to $10.25 billion, higher than analysts' estimates of $10.14 billion.

The results were in-line with the preview and the 2016 outlook was solid, Credit Suisse noted.

"Execution on strategy should drive favorable performance in 2016," the firm said in an analyst note.

The health care services company owns, manages or operates hospitals, freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers.

Shares of HCA are advancing by 4.19% to $70.34 on Friday afternoon.

Separately, TheStreet Ratings Team has a "Hold" rating with a score of C on the stock.

The primary factors that have impacted its rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks.

Among the primary strengths of the company is its revenue growth.

At the same time, the team also finds weaknesses including unimpressive growth in net income, weak operating cash flow and poor profit margins.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: HCA

Image placeholder title

HCA

data by

YCharts